Go to deals
Healthcare

Medicija has acquired Saulės Šeimos Medicinos Centras

May 2026 — Medicija has acquired a 100% stake in Saulės Šeimos Medicinos Centras.

Medicija is a leading fertility services provider in Lithuania with a growing offering across multiple specialist consultation areas. It operates three modern clinics in Vilnius, Kaunas and Klaipėda.

Founded 25 years ago by five family doctors, Saulės Šeimos Medicinos Centras is the largest primary healthcare provider in the Kaunas region, operating four state-of-the-art clinics in the city. The company serves approximately 28,000 registered patients and employs 170 people.

Our role in the transaction

Oaklins’ team in Lithuania acted as the financial advisor to Medicija in the acquisition. This transaction marks the team’s third engagement with Medicija, strengthening the company’s position in the Lithuanian healthcare services market and laying a solid foundation for future growth.

Parties

Talk to the deal team

Natalja Titova

Associate Partner
Vilnius, Lithuania
Oaklins Baltics

Related deals

Indigo Capital has acquired a minority stake in Vivason
Private Equity | Consumer & Retail | Healthcare

Indigo Capital has acquired a minority stake in Vivason

Indigo Capital has acquired a minority stake in Vivason, a leading network of hearing care centers, to support the company’s growth and enable management to increase its ownership stake.

Learn more
UKAT Group has acquired Bayberry Limited
Private Equity | Healthcare

UKAT Group has acquired Bayberry Limited

UK Addiction Treatment (UKAT) Group, a leading UK provider of residential addiction, mental health and behavioral health treatment backed by Sullivan Street Partners, has acquired Bayberry Limited, a specialist mental health and wellbeing treatment provider. Joining UKAT enables Bayberry to preserve continuity of care for patients and referral partners, retain the strength of its clinical team and benefit from UKAT’s operational infrastructure, referral network and marketing channels. This partnership supports Bayberry’s next stage of development while preserving the qualities that differentiate its service offering.

Learn more
Quimpharma has completed the divestiture of a product portfolio to Megalabs
Healthcare

Quimpharma has completed the divestiture of a product portfolio to Megalabs

Quimpharma has completed the divestiture of a product portfolio to Megalabs México.

Learn more